AbCellera Biologics (ABCL) Goodwill (2020 - 2026)

AbCellera Biologics' Goodwill history runs 7 years deep, the most recent figure standing at $47.8 million for Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.8 million (changed 0.0% YoY) and the FY2025 annual result came in at $47.8 million, changed 0.0% from the prior year.
• Goodwill was $47.8 million for Q1 2026 at AbCellera Biologics, roughly flat from $47.8 million in the prior quarter.
• Across five years, Goodwill topped out at $47.8 million in Q1 2022 and bottomed at $47.8 million in Q1 2022.
• A 5-year average of $47.8 million and a median of $47.8 million in 2022 frame the typical range for Goodwill.
• Peak annual rise in Goodwill reached 193.18% in 2022, while the deepest fall reached 3.34% in 2022.
• AbCellera Biologics' Goodwill stood at $47.8 million in 2022, then changed by 0.0% to $47.8 million in 2023, then changed by 0.0% to $47.8 million in 2024, then changed by 0.0% to $47.8 million in 2025, then changed by 0.0% to $47.8 million in 2026.
• Business Quant data shows ABCL's Goodwill at $47.8 million in Q1 2026, $47.8 million in Q4 2025, and $47.8 million in Q3 2025.